Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (K.V.P., J.V.-E., S.L., M.B.T., K.N.).
Harbor-UCLA Medical Center, Torrance, CA (M.J.B.).
Circ Cardiovasc Imaging. 2023 Oct;16(10):e015314. doi: 10.1161/CIRCIMAGING.123.015314. Epub 2023 Sep 29.
The contemporary burden and characteristics of coronary atherosclerosis, assessed using coronary computed tomography angiography (CCTA), is unknown among asymptomatic adults with diabetes and prediabetes in the United States. The pooled cohort equations and coronary artery calcium (CAC) score stratify atherosclerotic cardiovascular disease risk, but their association with CCTA findings across glycemic categories is not well established.
Asymptomatic adults without atherosclerotic cardiovascular disease enrolled in the Miami Heart Study were included. Participants underwent CAC and CCTA testing and were classified into glycemic categories. Prevalence of coronary atherosclerosis (any plaque, noncalcified plaque, plaque with ≥1 high-risk feature, maximal stenosis ≥50%) assessed by CCTA was described across glycemic categories and further stratified by pooled cohort equations-estimated atherosclerotic cardiovascular disease risk and CAC score. Adjusted logistic regression was used to evaluate the associations between glycemic categories and coronary outcomes.
Among 2352 participants (49.5% women), the prevalence of euglycemia, prediabetes, and diabetes was 63%, 30%, and 7%, respectively. Coronary plaque was more commonly present across worsening glycemic categories (euglycemia, 43%; prediabetes, 58%; diabetes, 69%), and similar pattern was observed for other coronary outcomes. In adjusted analyses, compared with euglycemia, prediabetes and diabetes were each associated with higher odds of any coronary plaque (OR, 1.30 [95% CI, 1.05-1.60] and 1.75 [1.17-2.61], respectively), noncalcified plaque (OR, 1.47 [1.19-1.81] and 1.99 [1.38-2.87], respectively), and plaque with ≥1 high-risk feature (OR, 1.65 [1.14-2.39] and 2.53 [1.48-4.33], respectively). Diabetes was associated with stenosis ≥50% (OR, 3.01 [1.79-5.08]; reference=euglycemia). Among participants with diabetes and estimated atherosclerotic cardiovascular disease risk <5%, 46% had coronary plaque and 10% had stenosis ≥50%. Among participants with diabetes and CAC=0, 30% had coronary plaque and 3% had stenosis ≥50%.
Among asymptomatic adults, worse glycemic status is associated with higher prevalence and extent of coronary atherosclerosis, high-risk plaque, and stenosis. In diabetes, CAC was more closely associated with CCTA findings and informative in a larger population than the pooled cohort equations.
在美国,患有糖尿病和糖尿病前期的无症状成年人中,使用冠状动脉计算机断层扫描血管造影(CCTA)评估的冠状动脉粥样硬化的当代负担和特征尚不清楚。汇总队列方程和冠状动脉钙化(CAC)评分可对动脉粥样硬化性心血管疾病风险进行分层,但它们与不同血糖类别之间的 CCTA 结果的相关性尚未得到很好的证实。
本研究纳入了无动脉粥样硬化性心血管疾病的无症状迈阿密心脏研究参与者。参与者接受 CAC 和 CCTA 检测,并根据血糖类别进行分类。通过 CCTA 评估了不同血糖类别的冠状动脉粥样硬化(任何斑块、非钙化斑块、有≥1 个高危特征的斑块、最大狭窄≥50%)的患病率,并根据汇总队列方程估计的动脉粥样硬化性心血管疾病风险和 CAC 评分进一步分层。采用校正逻辑回归评估血糖类别与冠状动脉结局之间的关系。
在 2352 名参与者(49.5%为女性)中,血糖正常、糖尿病前期和糖尿病的发生率分别为 63%、30%和 7%。随着血糖状况恶化,冠状动脉斑块更为常见(血糖正常,43%;糖尿病前期,58%;糖尿病,69%),其他冠状动脉结局也呈现类似模式。在调整分析中,与血糖正常相比,糖尿病前期和糖尿病患者发生任何冠状动脉斑块(比值比,1.30 [95%置信区间,1.05-1.60]和 1.75 [1.17-2.61])、非钙化斑块(比值比,1.47 [95%置信区间,1.19-1.81]和 1.99 [1.38-2.87])和有≥1 个高危特征的斑块(比值比,1.65 [95%置信区间,1.14-2.39]和 2.53 [1.48-4.33])的几率均更高。糖尿病与狭窄≥50%(比值比,3.01 [1.79-5.08];参考=血糖正常)相关。在患有糖尿病且估计的动脉粥样硬化性心血管疾病风险<5%的参与者中,有 46%存在冠状动脉斑块,有 10%存在狭窄≥50%。在患有糖尿病且 CAC=0 的参与者中,有 30%存在冠状动脉斑块,有 3%存在狭窄≥50%。
在无症状成年人中,血糖状况越差,冠状动脉粥样硬化、高危斑块和狭窄的发生率和严重程度越高。在糖尿病患者中,CAC 与 CCTA 结果的相关性更为密切,并且比汇总队列方程在更大的人群中更具信息性。